The canine keratosis treatment market is projected to grow from USD 666.0 million in 2026 to USD 1,359.9 million by 2036, at a CAGR of 7.4%. Topical treatments will dominate with a 54.0% market share, while hyperkeratosis will lead the applications segment with a 66.0% share.